GlassScriptPhysician profile
Krystal Dawn Deleon
NPI 1700375979
$5,183.51
in general payments reported to CMS, 2019-2025
38 companies · $910 in 2025
The $910 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $63.97 · 2021: $254 · 2022: $1,262 · 2023: $1,510 · 2024: $1,184 · 2025: $910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,585 · Debt Forgiveness: $18.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,584.77 |
| Debt Forgiveness | $18.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $774.16 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $587.71 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $582.17 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $512.95 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $477.19 | 2020-2025 | |
| Amgen INC. | $249.44 | 2021-2025 | Repatha, Otezla, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.09 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
| Abbvie INC. | $190.76 | 2022-2025 | Mavyret |
| Bayer Healthcare Pharmaceuticals INC. | $158.81 | 2021-2024 | |
| Abbott Laboratories | $157.38 | 2022-2024 | Proclaim, Freestyle Libre 3 |
| Mylan Specialty L.P. | $130.50 | 2022-2023 | Yupelri |
| Exact Sciences Corporation | $125.82 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $96.33 | 2022-2023 | |
| Cmp Pharma, INC. | $83.79 | 2022 | |
| Dexcom, INC. | $80.57 | 2022-2025 | Dexcom G6 Transmitter |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $79.89 | 2022-2025 | |
| Idorsia Pharmaceuticals US INC | $66.10 | 2022-2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $65.88 | 2023 | Xarelto |
| Antares Pharma, INC. | $60.58 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Abiomed | $43.34 | 2024 | Impella |
| Insulet Corporation | $41.02 | 2022 | |
| Stryker Corporation | $37.68 | 2024 | Ortholoc 3di Crosscheck |
| Ironshore Pharmaceuticals INC. | $35.51 | 2021-2024 | |
| Medtronic, INC. | $33.39 | 2023 | Intellis Adaptivestim, Vanta Adaptivestim |
| Otsuka America Pharmaceutical, INC. | $32.53 | 2022-2025 | Rexulti |
| Mimedx Group, INC. | $31.65 | 2024 | |
| Astellas Pharma US INC | $31.51 | 2025 | Veozah |
| Corcept Therapeutics | $30.69 | 2024 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.87 | 2022 | |
| Electromed, INC. | $19.47 | 2025 | Smartvest |
| Depuy Synthes Sales INC. | $16.78 | 2023 | Orthovisc, Peak |
| Eisai INC. | $16.48 | 2021 | |
| Sanofi Pasteur INC. | $16.37 | 2025 | |
| Amarin Pharma, INC. | $15.28 | 2021 | |
| Spinal Simplicity, LLC | $13.90 | 2025 | Ha Minuteman G3-R |
| Amneal Pharmaceuticals LLC | $12.77 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.37 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krystal Deleon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.